Kerala Ayurveda share news, announcements and annual reports
BSE: 530163Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹139.60.
30 Oct: open ₹144.35, high ₹144.35, low ₹137.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹192 Cr2,181st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −257.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −24.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 5.43
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,685
Kerala Ayurveda share news and announcements
558 announcements, routine notices left out, newest first. Page 9 of 12.
Jul 2018
12 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 011 Jul · Shareholding for the Period Ended June 30, 2018
Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....
Jun 2018
28 Jun · Business
May 2018
30 May · Results
Apr 2018
23 Apr · Compliance Under Regulation 40(9) Of SEBI LODR 2015
16 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....10 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 06 Apr · Compliance Certificate Under Regulation 7(3)
Feb 2018
Jan 2018
10 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....5 Jan · Status Of Investor Complaints Under Regulation 13(3) For The Quarter Ended 31St December, 2017
Nov 2017
11 Nov · Results
2 Nov · Board Meeting On 11/11/2017
Oct 2017
23 Oct · Compliance Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
17 Oct · Business
13 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....10 Oct · Statement Of Investor Complaints For The Quarter Ended 30The Sept.2017
3 Oct · Annual Report Of The Company For The Financial Year 2016-17
Sep 2017
30 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2017
2 Aug · Board Meeting On 11Th August, 2017
Jul 2017
15 Jul · Shareholding for the Period Ended June 30, 2017
Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....15 Jul · Status Of Investor Complaints Under Regulation 13(3) For The Quarter Ended 30Th June, 2017
Jun 2017
May 2017
29 May · Board meeting
19 May · Board Meeting On 29Th May, 2017
Apr 2017
24 Apr · Compliance Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015,
20 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....13 Apr · Status Of Investor Complaints For The Quarter Ended 31St March, 2017 Submitted Under Regulation 13(3) Of SEBI(LODR) Regulations, 2015